Ocera Therapeutics, Inc.
OCRX
OCRX was delisted on the 8th of December, 2017.
34 hedge funds and large institutions have $30.7M invested in Ocera Therapeutics, Inc. in 2015 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 9 closing their positions.
10% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 10
17% less funds holding
Funds holding: 41 → 34 (-7)
33% less capital invested
Capital invested by funds: $46M → $30.7M (-$15.3M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$602K |
| 2 |
OPPM
Opus Point Partners Management
New York
|
+$346K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$316K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$210K |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$119K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$4.04M |
| 2 |
DM
Deerfield Management
New York
|
-$2.94M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$576K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$434K |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$294K |
OCRX Hedge Fund Activity: Q1 2015 in Review
34 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Ocera Therapeutics, Inc. (OCRX) for Q1 2015, worth a combined $30.7M — down 33% from $46M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of OCRX and 2 opened new positions — a net loss of 7 holders — while 10 trimmed existing stakes and 11 added.
The largest buyer was Millennium Management, adding an estimated $602K. The largest seller was DAFNA Capital Management, exiting entirely with an estimated $4.04M sold.
- 34 institutional investors held Ocera Therapeutics, Inc. (OCRX) as of Q1 2015, down from 41 in Q4 2014.
- Funds reported $30.7M of Ocera Therapeutics, Inc. stock for Q1 2015, down 33% quarter-over-quarter.
- 2 funds opened new Ocera Therapeutics, Inc. positions in Q1 2015 and 9 closed out, a net change of -7 holders.
- The largest Ocera Therapeutics, Inc. buyer in Q1 2015 was Millennium Management, an estimated $602K added.
- The largest Ocera Therapeutics, Inc. seller in Q1 2015 was DAFNA Capital Management, an estimated $4.04M sold.
Based on aggregated 13F filings for Q1 2015.